Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$98.32 USD

98.32
21,578,090

-0.84 (-0.85%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $98.81 +0.49 (0.50%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 43% (106 out of 247)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Mark Vickery headshot

Playing the Waiting Game; Plus MedTech, Pharma in Q3 Earnings

by Mark Vickery

We won't get the final numbers until later, so until then we're just playing the waiting game.

Zacks Equity Research

CVS Health (CVS) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

CVS Health (CVS) delivered earnings and revenue surprises of 1.17% and 0.17%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Benjamin Rains headshot

What to Expect from CVS Health's Q3 Earnings

by Benjamin Rains

Let's see what to expect from CVS before the opening bell Tuesday.

Benjamin Rains headshot

Should You Buy CVS Stock Ahead of Q3 Earnings?

by Benjamin Rains

Let's see if investors should think about buying CVS stock ahead of its Q3 financial results.

Ryan McQueeney headshot

Upcoming Earnings Reports to Watch: CVS, QCOM, DIS

by Ryan McQueeney

Stocks were down in morning trading Friday, putting major indexes on track to snap a three-day winning streak that followed a brutal month of selling. But will next week's earnings results get the rebound back on track? Let's take a closer look at a few of the earnings announcements due during the week of November 5!

Zacks Equity Research

CVS Health (CVS) Gains But Lags Market: What You Should Know

by Zacks Equity Research

CVS Health (CVS) closed the most recent trading day at $72.84, moving +0.61% from the previous trading session.

Zacks Equity Research

Will CVS Health's (CVS) PBM Strength Boost Q3 Earnings?

by Zacks Equity Research

Despite a challenging pricing scenario, CVS Health (CVS) is currently gaining on high level of service and execution as well as a competitive pricing along with unique integrated model.

Zacks Equity Research

Aetna (AET) Q3 Earnings Beat Estimates, Membership Increases

by Zacks Equity Research

Aetna (AET) earnings grow on revenue and membership gains.

Zacks Equity Research

CVS Health (CVS) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

CVS Health (CVS) Gains But Lags Market: What You Should Know

by Zacks Equity Research

CVS Health (CVS) closed the most recent trading day at $70.67, moving +1.23% from the previous trading session.